Bangladesh has highlighted the need to use the knowledge and global experience of expatriate Bangladeshi scientists to make the country’s pharmaceutical industry stronger and more competitive in international markets. This idea is important because the pharmaceutical sector is already one of Bangladesh’s most promising industries. Local companies produce a large share of the medicines used at home and are also reaching foreign markets. However, the next stage of growth will need more advanced research, biotechnology skills, biosimilar development, quality systems, and global regulatory knowledge. Bangladeshi scientists and researchers working abroad can play a valuable role in this journey. Many of them have experience in modern laboratories, drug research, biotechnology, clinical science, manufacturing standards, and international approval systems. If their knowledge is connected with local companies, universities, research centers, and policy support, Bangladesh can move toward higher-value pharmaceutical production. The focus on biotech and biosimilar medicines is especially important. Biosimilars are advanced medicines related to biological products and require strong scientific skill, testing, and production control. Countries that develop capacity in this field can serve growing global healthcare needs. For Bangladesh, this can open a path beyond traditional generic medicines and create new export opportunities. Expatriate professionals can help through research collaboration, training, advisory support, joint projects, technology transfer, and mentoring young scientists. They can also help local institutions understand global standards and market requirements. This can reduce the gap between local production strength and international research capacity. The idea also supports the modernization of healthcare and pharmaceutical services. Stronger research can lead to better medicine quality, more specialized products, and improved confidence among global buyers. It can also help create skilled jobs for pharmacists, chemists, biotechnologists, engineers, and laboratory professionals. To make this work, Bangladesh needs a clear platform where expatriate experts can connect with local industry and research bodies. Universities need better labs, companies need investment in research, and young scientists need training opportunities. Policy support can encourage partnerships, protect quality, and make collaboration easier. The pharmaceutical sector has the potential to become a larger source of export earnings and scientific progress. By welcoming the expertise of Bangladeshi professionals abroad, the country can build a stronger bridge between local industry and global knowledge. If this connection grows, Bangladesh’s pharma industry can become more innovative, research-driven, and respected in international healthcare markets.
